Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 20 results:
Author Title Type [ Year(Asc)]
Filters: Author is Zhang, W.  [Clear All Filters]
2021
S. Swain, Coupland, C., Mallen, C., Kuo, C. F., Sarmanova, A., Bierma-Zeinstra, S. M. A., Englund, M., Prieto-Alhambra, D., Doherty, M., and Zhang, W., “Temporal relationship between osteoarthritis and comorbidities: a combined case control and cohort study in the UK primary care setting”, Rheumatology (Oxford), 2021.
G. Nakafero, Grainge, M. J., Card, T., Mallen, C. D., Zhang, W., Doherty, M., Taal, M. W., Aithal, G. P., and Abhishek, A., “What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?”, Rheumatology (Oxford), 2021.
G. Nakafero, Grainge, M. J., Valdes, A. M., Townsend, N., Mallen, C., Zhang, W., Doherty, M., Mamas, M., and Abhishek, A., “β-blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score matched cohort study”, Rheumatology (Oxford), 2021.
2020
G. Nakafero, Grainge, M. J., Myles, P. R., Mallen, C. D., Zhang, W., Doherty, M., Nguyen-Van-Tam, J. S., and Abhishek, A., “Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs”, Rheumatology (Oxford), 2020.
A. Sarmanova, Doherty, M., Kuo, C., Wei, J., Abhishek, A., Mallen, C., Zeng, C., Wang, Y., Lei, G., and Zhang, W., “Statin use and risk of joint replacement due to osteoarthritis and rheumatoid arthritis: a propensity-score matched longitudinal cohort study”, Rheumatology (Oxford), 2020.
S. Swain, Sarmanova, A., Mallen, C., Kuo, C. F., Coupland, C., Doherty, M., and Zhang, W., “Trends in incidence and prevalence of osteoarthritis in the United Kingdom: findings from the Clinical Practice Research Datalink (CPRD)”, Osteoarthritis Cartilage, 2020.
2019
G. Nakafero, Grainge, M. J., Myles, P. R., Mallen, C. D., Zhang, W., Doherty, M., Nguyen-Van-Tam, J. S., and Abhishek, A., “Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink”, Ann Rheum Dis, 2019.
G. Nakafero, Grainge, M., Valdes, A., Townsend, N., Mallen, C., Zhang, W., Doherty, M., Mamas, M. A., and Abhishek, A., “Do beta-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink”, BMJ Open, vol. 9, p. e032050, 2019.
2018
G. Nakafero, Grainge, M. J., Myles, P. R., Mallen, C. D., Zhang, W., Doherty, M., Nguyen-Van-Tam, J. S., and Abhishek, A., “Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK: a nationwide prospective cohort study”, Rheumatology (Oxford), vol. 57, pp. 1726-1734, 2018.
A. Abhishek, Nakafero, G., Kuo, C. F., Mallen, C., Zhang, W., Grainge, M. J., and Doherty, M., “Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research Datalink”, Rheumatology (Oxford), vol. 57, pp. 977-981, 2018.
C. F. Kuo, Chou, I. J., See, L. C., Chen, J. S., Yu, K. H., Luo, S. F., Hsieh, A. H., Zhang, W., and Doherty, M., “Urate-lowering treatment and risk of total joint replacement in patients with gout”, Rheumatology (Oxford), vol. 57, pp. 2129-2139, 2018.
2017
F. Rees, Doherty, M., Lanyon, P., Davenport, G., Riley, R. D., Zhang, W., and Grainge, M. J., “Early Clinical Features in Systemic Lupus Erythematosus: Can They Be Used to Achieve Earlier Diagnosis? A Risk Prediction Model”, Arthritis Care Res (Hoboken), vol. 69, pp. 833-841, 2017.
A. Abhishek, Doherty, M., Kuo, C. F., Mallen, C. D., Zhang, W., and Grainge, M. J., “Rheumatoid arthritis is getting less frequent-results of a nationwide population-based cohort study”, Rheumatology (Oxford), vol. 56, pp. 736-744, 2017.
2016
F. Rees, Doherty, M., Grainge, M., Lanyon, P., Davenport, G., and Zhang, W., “Burden of Comorbidity in Systemic Lupus Erythematosus in the UK, 1999-2012”, Arthritis Care Res (Hoboken), vol. 68, pp. 819-27, 2016.
C. F. Kuo, Grainge, M. J., Mallen, C., Zhang, W., and Doherty, M., “Comorbidities in patients with gout prior to and following diagnosis: case-control study”, Ann Rheum Dis, vol. 75, pp. 210-7, 2016.
C. F. Kuo, Grainge, M. J., Mallen, C., Zhang, W., and Doherty, M., “Impact of gout on the risk of atrial fibrillation”, Rheumatology (Oxford), vol. 55, pp. 721-8, 2016.
F. Rees, Doherty, M., Grainge, M., Davenport, G., Lanyon, P., and Zhang, W., “The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012”, Ann Rheum Dis, vol. 75, pp. 136-41, 2016.
F. Rees, Doherty, M., Grainge, M. J., Lanyon, P., Davenport, G., and Zhang, W., “Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012”, Rheumatology (Oxford), vol. 55, pp. 854-60, 2016.
2015
C. F. Kuo, Grainge, M. J., Mallen, C., Zhang, W., and Doherty, M., “Effect of allopurinol on all-cause mortality in adults with incident gout: propensity score-matched landmark analysis”, Rheumatology (Oxford), vol. 54, pp. 2145-50, 2015.
C. F. Kuo, Grainge, M. J., Mallen, C., Zhang, W., and Doherty, M., “Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study”, Ann Rheum Dis, vol. 74, pp. 661-7, 2015.
[Page last reviewed 6 April 2021]